WebRITUXAN for the treatment of follicular CD20-positive non-Hodgkin's lymphoma as an initial treatment with chemotherapy, and in patients whose initial treatment was successful, … WebJul 5, 2024 · CLL is an extremely heterogeneous disease, and patients do not merit treatment until their disease has progressed and become symptomatic. 14 A number of …
Arzerra™ Treatment for Chronic Lymphocytic Leukemia
WebDec 14, 2016 · SAN DIEGO – Lenalidomide, a mainstay of maintenance therapy for multiple myeloma, is now making inroads into maintenance therapy following first- and second-line therapy for chronic lymphocytic leukemia (CLL), investigators reported in two phase III studies. WebNov 13, 2024 · However maintenance therapy of anti-CD20 antibodies, although approved in some other B-cell malignancies, is not yet approved in CLL by regulators. Aim. We … jan sonneveld by speech
Ofatumumab Approved as Maintenance Therapy for CLL
WebMar 13, 2014 · Tools. Richter syndrome (RS) is defined as the transformation of chronic lymphocytic leukemia (CLL) into an aggressive lymphoma, most commonly diffuse large B-cell lymphoma (DLBCL). RS occurs in approximately 2% to 10% of CLL patients during the course of their disease, with a transformation rate of 0.5% to 1% per year. WebApr 24, 2024 · Rituxan is commonly used for the initial treatment and as maintenance therapy fo B-cell non-Hodgkin’s lymphomas (NHL) and chronic lymphocytic leukemia … WebJan 14, 2010 · I do not administer maintenance therapy in CLL, because this has no established role at present. Alemtuzumab has been assessed in this setting with some intriguing results obtained, 66 but enthusiasm has been tempered by the high toxicity observed. Ongoing clinical trials are examining maintenance therapy with rituximab, … janson history of art women artists